| 【Company Research】WuXi Biologics (2269 HK) – Non-COVID projects driving long-term growth |
| 【Company Research】Geely (175 HK) – Zeekr trending up; Other brands still uncertain |
| 【Company Research】NetEase Inc. (NTES US) – Strong pipeline despite short-term deceleration |
| 【Company Research】ZTO Express (ZTO US) – Record-high market share; Good cost control; Earnings raised on better margin |
| 【Company Research】ZTO Express (2057 HK) – Record-high market share; Good cost control; Earnings raised on better margin |
| 【Company Research】I-Mab BioPharma (IMAB US) – Amendment on the deal regarding anti-CD47 antibodies with AbbVie |
| 【Company Research】CR Beer (291 HK) – 1H22 beat on better cost efficiency; our top pick over 2H22 |
| 【Company Research】Tencent (700 HK) – Eyes on efficiency and video accounts upside |
| 【Company Research】Sunny Optical (2382 HK) – Shipment guidance lowered as expected; Awaiting market recovery |
| 【Company Research】Vesync (2148 HK) – Sales and cost pressure may persist in 2H22E |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
